The global enteral stents market is expected to grow from US$ 1.2 billion in 2023 to US$ 2.5 billion by 2030, at a CAGR of 12.7% during the forecast period. Several factors are driving the growth of the enteral stents market, including the rising prevalence of gastrointestinal disorders, increasing awareness of minimally invasive procedures, and technological advancements in enteral stents.

Enteral stents are medical devices used to treat blockages or strictures in the gastrointestinal (GI) tract. They are typically made of metal or plastic and are inserted into the GI tract through an endoscope. Enteral stents can help to improve the flow of food, fluids, and bile through the GI tract, and they can also help to relieve symptoms such as pain, nausea, and vomiting.

To Get the Sample Copy of Report Visit! https://absolutemarketresearch.com/Global-Enteral-Stents-Market/1106/request-sample

There are two main types of enteral stents: self-expanding and balloon-expandable. Self-expanding stents are made of a nitinol mesh that expands when it is placed in the body. Balloon-expandable stents are made of a plastic tube that is inserted into the body and then inflated with a balloon. Balloon-expandable stents are more commonly used than self-expanding stents.

The enteral stents market is dominated by a few large players, including Boston Scientific, Cook Medical, and Medtronic. However, there are also a number of smaller players in the market, such as Merit Medical Systems and Taewoong Medical.

The enteral stents market is expected to grow in the coming years, driven by the factors mentioned above. In addition, the growing demand for minimally invasive procedures and the increasing adoption of new technologies, such as bioabsorbable stents, are also expected to contribute to the growth of the market.

Benefits of Enteral Stent Placement:

Enteral stent placement has several benefits over surgery, including:

  • It is a minimally invasive procedure that can be performed in an outpatient setting.
  • It is associated with fewer complications than surgery.
  • It can be used in patients who are not candidates for surgery.

Risks of Enteral Stent Placement:

Enteral stent placement also has some risks, including:

  • Stent migration: Stents can move from their original position, which can block the GI tract or cause other problems.
  • Stent occlusion: Stents can become blocked by food or other debris, which can cause symptoms such as nausea, vomiting, and pain.
  • Tissue ingrowth: Tissue can grow into the stent, which can make it difficult to remove the stent.
  • Bleeding: Stent placement can cause bleeding, although this is usually minor.
  • Perforation: In rare cases, stent placement can cause a perforation in the GI tract.

Overall, enteral stents are a safe and effective treatment for a variety of GI conditions. They can help to improve symptoms, quality of life, and survival in patients with malignant and benign GI obstructions.

Key Takeaways:

  • The global enteral stents market is expected to grow from US$ 1.2 billion in 2023 to US$ 2.5 billion by 2030, at a CAGR of 12.7% during the forecast period.
  • Increasing prevalence of gastrointestinal diseases, rising geriatric population, and technological advancements are driving market growth.
  • Self-expanding metal stents (SEMS) are expected to dominate the market due to their superior efficacy and safety compared to plastic stents.
  • North America is the largest market, followed by Europe and Asia Pacific.
  • Emerging markets such as China and India are expected to witness significant growth due to increasing healthcare awareness and affordability.

Regional Outlook:

  • North America: Dominates the market due to high prevalence of gastrointestinal diseases, established healthcare infrastructure, and favorable reimbursement policies.
  • Europe: Second-largest market with significant opportunities for growth due to increasing geriatric population and rising healthcare spending.
  • Asia Pacific: Expected to witness the fastest growth due to rising disposable incomes, increasing awareness about enteral stents, and growing healthcare infrastructure.
  • Latin America: Relatively small market with potential for growth due to expanding healthcare sector and increasing access to medical technologies.
  • Middle East & Africa: Smallest market due to limited healthcare infrastructure and low awareness about enteral stents.

Key Players:

  • Boston Scientific Corporation
  • Cook Medical
  • Medtronic plc
  • Taewoong Medical
  • B. Braun Melsungen AG
  • Micro-Tech (Nanjing) Co., Ltd.
  • Apollo Endosurgery
  • C.R. Bard, Inc.
  • Conmed Corporation
  • Stryker Corporation

Segmentation:

By Product:

  • Self-expanding metal stents (SEMS)
  • Plastic stents
  • Covered stents
  • Uncovered stents

By Application:

  • Esophageal stents
  • Gastric stents
  • Duodenal stents
  • Colonic stents
  • Others

By End User:

  • Hospitals
  • Ambulatory surgical centers
  • Clinics

By Geography:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa